Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Active and recent NIH-funded research on Arrhythmogenic Right Ventricular Cardiomyopathy. Data from NIH RePORTER, last 36 months.
Arrhythmogenic Right Ventricular Cardiomyopathy has active NIH research funding with 10 funded grants totaling $15.3M.
1 new grant started in the last 12 months.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Arrhythmogenic Right Ventricular Cardiomyopathy. Strongest funded area: Basic Science. Largest gap: Epidemiology / Natural History.
37 publications in Diagnostic / Biomarker but no NIH-funded grants found in Biomarker / Diagnostics for arrhythmogenic right ventricular cardiomyopathy. Existing research activity suggests this may be a viable area for grant applications.
61 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for arrhythmogenic right ventricular cardiomyopathy. Existing research activity suggests this may be a viable area for grant applications.
36 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for arrhythmogenic right ventricular cardiomyopathy. Existing research activity suggests this may be a viable area for grant applications.